Last 48.05 INR
Change Today +0.60 / 1.26%
Volume 7.3K
LPH On Other Exchanges
Symbol
Exchange
Mumbai
As of 10:00 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

lincoln pharmaceuticals ltd (LPH) Snapshot

Open
47.45
Previous Close
47.45
Day High
48.70
Day Low
47.45
52 Week High
09/12/14 - 60.00
52 Week Low
10/28/13 - 26.65
Market Cap
783.7M
Average Volume 10 Days
13.4K
EPS TTM
3.14
Shares Outstanding
16.3M
EX-Date
09/25/14
P/E TM
15.3x
Dividend
0.60
Dividend Yield
1.25%
Current Stock Chart for LINCOLN PHARMACEUTICALS LTD (LPH)

Related News

No related news articles were found.

lincoln pharmaceuticals ltd (LPH) Related Businessweek News

No Related Businessweek News Found

lincoln pharmaceuticals ltd (LPH) Details

Lincoln Pharmaceuticals Limited manufactures, markets, and exports pharmaceuticals products in India and internationally. Its product categories comprise antimalarial, antibiotics, anti-bactarials, analgesics, anti-inflammatory, anti-hypertensives, anti-fungal, antacids, anti-ulcers, anthelmintics, anti-cold, anti-allergic, anti-asthmatics, anti-emetics, gastrointestinal-agents, anti-diarrhoeals, anti-spasmodics, and pro-biotics. The company also offers cream, ointment, anti-infectives, vitamins, minerals, and iron-preparations. In addition, it also trades finished goods, chemicals products, and bulk drugs. The company was founded in 1979 and is based in Ahmedabad, India.

Founded in 1979

lincoln pharmaceuticals ltd (LPH) Top Compensated Officers

Joint Managing Director and Director
Total Annual Compensation: 1.2M
Managing Director, Whole Time Director, Membe...
Total Annual Compensation: 1.2M
Whole-Time Director and Member of Shareholder...
Total Annual Compensation: 1.2M
Compliance Officer, Whole-Time Director and M...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

lincoln pharmaceuticals ltd (LPH) Key Developments

Lincoln Pharmaceuticals Ltd., Annual General Meeting, Sep 30, 2014

Lincoln Pharmaceuticals Ltd., Annual General Meeting, Sep 30, 2014., at 10:30 Indian Standard Time. Location: LINCOLN HOUSE, Behind Satyam Complex, Science City Road.

Lincoln Pharmaceuticals Ltd. Reports Unaudited Consolidated and Standalone Earnings Results for the First Quarter Ended June 30, 2014

Lincoln Pharmaceuticals Ltd. Reported unaudited consolidated and standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the group reported net sales of INR 469.495 million, profit from operations before other income, finance costs and exceptional items of INR 60.593 million, profit from ordinary activities before tax of INR 42.123 million and net profit after taxes, minority interest and share of associates of INR 32.284 million or INR 1.98 per diluted share after extraordinary items (not annualised) compared to net sales of INR 379.538 million, profit from operations before other income, finance costs and exceptional items of INR 41.818 million, profit from ordinary activities before tax of INR 27.295 million and net profit after taxes, minority interest and share of associates of INR 32.410 million or INR 1.99 per diluted share after extraordinary items (not annualised) reported in the same period last year. For the quarter, the parent company reported net sales of INR 463.706 million, profit from operations before other income, finance costs and exceptional items of INR 64.528 million, profit from ordinary activities before tax of INR 50.718 million and net profit after taxes, minority interest and share of associates of INR 38.461 million or INR 2.36 per diluted share after extraordinary items (not annualised) compared to net sales of INR 374.260 million, profit from operations before other income, finance costs and exceptional items of INR 37.617 million, profit from ordinary activities before tax of INR 28.305 million and net profit after taxes, minority interest and share of associates of INR 35.004 million or INR 2.15 per diluted share after extraordinary items (not annualised) reported in the same period last year.

Lincoln Pharmaceuticals Ltd., Board Meeting, Aug 14, 2014

Lincoln Pharmaceuticals Ltd., Board Meeting, Aug 14, 2014. Agenda: To consider unaudited consolidated and standalone earnings results for the first quarter ended June 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LPH:IN 48.05 INR +0.60

LPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LPH.
View Industry Companies
 

Industry Analysis

LPH

Industry Average

Valuation LPH Industry Range
Price/Earnings 7.2x
Price/Sales 0.4x
Price/Book 0.8x
Price/Cash Flow 5.3x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LINCOLN PHARMACEUTICALS LTD, please visit www.lincolnpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.